Post-COVID Cancer Screenings Up but Racial Divide Remains
Cancer screening tests rebounded in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic.
Read MorePosted by Chris Wolski | Jul 9, 2021 | Cancer |
Cancer screening tests rebounded in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic.
Read MorePosted by Melanie Hamilton-Basich | Jul 7, 2021 | Kidney Disease |
Rhabdomyolysis (rhabdo for short) is a sometimes fatal condition caused by overexertion that results in overtaxed muscle cells bursting and dying, releasing toxins into the body. Experts worry many people returning to the gym after a COVID-19 pandemic hiatus might push themselves too hard and wind up diagnosed with rhabdo, reports the Washington Post.
Read MorePosted by Chris Wolski | Jul 6, 2021 | Molecular Diagnostics |
Seegene announced that it has signed a partnership with Bio-Rad for the development of infectious disease molecular diagnostic products.
Read MorePosted by Chris Wolski | Jul 2, 2021 | Covid 19, Rapid Assays |
Enzo Biochem, Inc., and CLX Health have announced a collaboration to provide rapid access to COVID-19 PCR testing for international travel.
Read MorePosted by Chris Wolski | Jun 30, 2021 | Miscellaneous |
U.S. Reps. Diana DeGette (D-CO) and Larry Bucshon, M.D. (R-IN) have announced that they have...
Read More